Skip to content
TrialScanner

NCT03980730

Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

Phase 2TerminatedVTVTLead

Registry record

Lead sponsor
vTv Therapeutics
Conditions
Alzheimer Disease
Primary completion
Dec 1, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03980730 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03980730: Study of Azeliragon in... | TrialScanner